HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shin-Ruen Yang Selected Research

tris(dibenzylideneacetone)dipalladium

12/2020Tris DBA ameliorates IgA nephropathy by blunting the activating signal of NLRP3 inflammasome through SIRT1- and SIRT3-mediated autophagy induction.
1/2020Tris DBA Ameliorates Accelerated and Severe Lupus Nephritis in Mice by Activating Regulatory T Cells and Autophagy and Inhibiting the NLRP3 Inflammasome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shin-Ruen Yang Research Topics

Disease

5Lupus Nephritis
01/2021 - 01/2019
3Inflammation (Inflammations)
11/2021 - 01/2020
2Glomerulonephritis
01/2021 - 01/2020
2IGA Glomerulonephritis (IGA Nephropathy)
01/2021 - 12/2020
2Multiple Myeloma
12/2020 - 01/2020
2Pancreatic Neoplasms (Pancreatic Cancer)
12/2020 - 01/2020
2Albuminuria
12/2020 - 01/2020
1Ureteral Obstruction
11/2021
1Fibrosis (Cirrhosis)
11/2021
1Chronic Renal Insufficiency
01/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Chronic Kidney Failure (Chronic Renal Failure)
01/2021
1Sclerosis
12/2020
1Neoplasms (Cancer)
12/2020
1Necrosis
01/2020
1Lymphoid Leukemia
01/2020
1Proteinuria
01/2019
1Nephritis
01/2019

Drug/Important Bio-Agent (IBA)

6InflammasomesIBA
01/2021 - 01/2019
4Therapeutic UsesIBA
11/2021 - 01/2019
3Pharmaceutical PreparationsIBA
11/2021 - 01/2020
2Antigen-Antibody Complex (Immune Complex)IBA
01/2021 - 12/2020
2benzamideIBA
01/2021 - 01/2021
2PalladiumIBA
12/2020 - 01/2020
2tris(dibenzylideneacetone)dipalladiumIBA
12/2020 - 01/2020
1CytokinesIBA
11/2021
1honokiolIBA
10/2020
1Sirtuin 1IBA
10/2020
1XenonIBA
01/2020
1Plant ExtractsIBA
01/2019
1GinsenosidesIBA
01/2019